Free Access
| Issue |
Med Sci (Paris)
Volume 41, Novembre 2025
Les Cahiers de Myologie
|
|
|---|---|---|
| Page(s) | 28 - 31 | |
| Section | Prise en charge | |
| DOI | https://doi.org/10.1051/medsci/2025181 | |
| Published online | 28 November 2025 | |
- Agence nationale d’accréditation et d’évaluation en santé, Association française contre les myopathies. Modalités, indications, limites de la rééducation dans les pathologies neuromusculaires non acquises (à l’exclusion du drainage bronchique et de la ventilation mécanique). Conférence de consensus, mercredi 26 et jeudi 27 septembre 2001, Centre de Conférences – Génocentre – Évry. Paris : ANAES 2001. [Google Scholar]
- Birnkrant DJ, Bushby K, Bann CM, et al. DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol. 2018 ; 17 (4) : 347–61. [Google Scholar]
- Mercuri E, Finkel RS, Muntoni F, et al. SMA Care Group. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018 ; 28 (2) : 103–15. [Google Scholar]
- Wang CH, Dowling JJ, North K, et al. Consensus statement on standard of care for congenital myopathies. J Child Neurol. 2012 ; 27 (3) : 363–82. [Google Scholar]
- Wang CH, Bonnemann CG, Rutkowski A, et al. International Standard of Care Committee for Congenital Muscular Dystrophy. Consensus statement on standard of care for congenital muscular dystrophies. J Child Neurol. 2010 ; 25 (12) : 1559–81. [Google Scholar]
- Rééducation de l’appareil locomoteur dans les pathologies neuromusculaires à la suite de l’introduction de nouvelles technologies (biothérapie, Instrumentation rachidienne, réentraînement à l’effort) – Argumentaire. HAS AFM-Téléthon 2024. [Google Scholar]
- National Institute for Health and Care Excellence. Motor neurone disease: assessment and management. NICE guideline 2016. [Google Scholar]
- Wu JW, Pepler L, Maturi B, et al. Systematic review of motor function scales and patient-reported outcomes in spinal muscular atrophy. Am J Phys Med Rehabil. 2022 ; 101 (6) : 590–608. [Google Scholar]
- de Lattre C, Vuillerot C, Bérard C, et al. Motor function measure: validation of a short form for young children with neuromuscular disease. Arch Phys Med Rehabil. 2013 ; 94 (11) : 2218–26. [Google Scholar]
- Dany A, Réveillère C, Bassez G, et al. The quality of life in genetic neuromuscular disease questionnaire: Rasch validation of the French version. Muscle Nerve 2017 ; 56 (6) : 1085–91. [Google Scholar]
- Organisation mondiale de la santé. CIF. Classification internationale du fonctionnement, du handicap et de la santé. Genève : OMS 2001. [Google Scholar]
- Organisation mondiale de la santé. CIF-EA. Classification internationale du fonctionnement, du handicap et de la santé. Version pour enfants et adolescents. Genève : OMS 2012. [Google Scholar]
- Lombardo ME, Carraro E, Sancricca C, et al. Management of motor rehabilitation in individuals with muscular dystrophies. 1stConsensus Conference report from UILDM – Italian Muscular Dystrophy Association (Rome, january 25-26,2019). Acta Myol. 2021 ; 40 (2) : 72–87. [Google Scholar]
- Lazovic M, Nikolic D, Boyer FC, et al. Evidence based position paper on Physical and Rehabilitation Medicine practice for people with muscular dystrophies. Eur J Phys Rehabil Med. 2021 ; 57 (6) : 1036–44. [Google Scholar]
- Araujo AP, Nardes F, Fortes CP, et al. Brazilian consensus on Duchenne muscular dystrophy. Part 2: rehabilitation and systemic care. Arq Neuropsiquiatr. 2018 ; 76 (7) : 481–9. [Google Scholar]
- Llerena Junior JC, Nascimento OJ, Oliveira AS, et al. Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease. Arq Neuro psiquiatr. 2016 ; 74 (2) : 166–76. [Google Scholar]
- Birnkrant DJ, Bushby K, Bann CM, et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018 ; 17 (3) : 251–67. [Google Scholar]
- Jones K, Hawke F, Newman J, et al. Interventions for promoting physical activity in people with neuromuscular disease. Cochrane Database of Systematic Reviews 2021 ; Issue 5 : CD013544. [Google Scholar]
- Cunin V. Early-onset scoliosis: current treatment. Orthop Traumatol Surg Res. 2015 ; 101 (1 Suppl) : S109–18. [Google Scholar]
- Skaggs DL, Akbarnia BA, Flynn JM, et al. A classification of growth friendly spine implants. J Pediatr Orthop 2014 ; 34 (3) : 260–74. [Google Scholar]
- Attarian S, Salort-Campana E, Urtizberea JA, et al. Recommendations for the management of facioscapulohumeral muscular dystrophyin 2011. Rev Neurol. 2012 ; 168 (12) : 910–8. [Google Scholar]
- Cheuk DK, Wong V, Wraige E, Baxter P, et al. Surgery for scoliosis in Duchenne muscular dystrophy. Cochrane Database of Systematic Reviews 2015 ; Issue 10 : CD005375. [Google Scholar]
- Kemoun G, Pélissier J. Réentrainement à l’effort. Paris : Éditions Frison-Roche 1999. [Google Scholar]
- Rééducation de l’appareil locomoteur dans les pathologies neuromusculaires à la suite de l’introduction de nouvelles technologies (biothérapie, Instrumentation rachidienne, réentraînement à l’effort) – Recommandation. HAS AFM-Téléthon 2024 https://www.has-sante.fr/upload/docs/application/pdf/2024-02/_reco408_recommandation_neuromusculaire_cd_20240118_vulg_sl.pdf [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.
